These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22506660)

  • 1. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.
    Olsen JA; Ahring PK; Kastrup JS; Gajhede M; Balle T
    J Biol Chem; 2014 Sep; 289(36):24911-21. PubMed ID: 24982426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the mechanism of action of NS9283, a positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors.
    Grupe M; Jensen AA; Ahring PK; Christensen JK; Grunnet M
    Br J Pharmacol; 2013 Apr; 168(8):2000-10. PubMed ID: 23278456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats.
    Mohler EG; Franklin SR; Rueter LE
    Psychopharmacology (Berl); 2014 Jan; 231(1):67-74. PubMed ID: 23925734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
    Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
    J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
    Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological modulation of the P3-like event-related potential in a rat two-tone auditory discrimination task with modafinil and NS9283, a positive allosteric modulator of α4β2 nAChRs.
    Grupe M; Grunnet M; Laursen B; Bastlund JF
    Neuropharmacology; 2014 Apr; 79():444-55. PubMed ID: 24361451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors.
    Kowal NM; Ahring PK; Liao VWY; Indurti DC; Harvey BS; O'Connor SM; Chebib M; Olafsdottir ES; Balle T
    Br J Pharmacol; 2018 Jul; 175(14):2911-2925. PubMed ID: 29669164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interface.
    Ahring PK; Olsen JA; Nielsen EØ; Peters D; Pedersen MH; Rohde LA; Kastrup JS; Shahsavar A; Indurthi DC; Chebib M; Gajhede M; Balle T
    Neuropharmacology; 2015 May; 92():135-45. PubMed ID: 25595102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Potentiation of the (α4)
    Appiani R; Viscarra F; Biggin PC; Bermudez I; Giraudo A; Pallavicini M; Bolchi C
    ACS Chem Neurosci; 2024 Apr; 15(7):1501-1514. PubMed ID: 38511291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors.
    Papke RL
    Biochem Pharmacol; 2024 Jul; 225():116263. PubMed ID: 38735444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.
    Carbone AL; Moroni M; Groot-Kormelink PJ; Bermudez I
    Br J Pharmacol; 2009 Mar; 156(6):970-81. PubMed ID: 19366353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.